Trials / Sponsors / Lomond Therapeutics Holdings, Inc.
Lomond Therapeutics Holdings, Inc.
Industry · 5 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients Acute Myeloid Leukemia | Phase 1 | 2026-01-10 |
| Recruiting | A Phase 1 Study of ZE50-0134 in Relapsed and Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lympho CLL / SLL, CLL (Chronic Lymphocytic Leukemia), SLL (Small Lymphocytic Lymphoma) | Phase 1 | 2025-04-08 |
| Recruiting | Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FL AML With Gene Mutations | Phase 1 | 2024-05-29 |
| Completed | Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Healthy | Phase 1 | 2024-05-21 |
| Completed | Study of Single and Multiple Ascending Doses of ZE46-0134 in Healthy Volunteers AML | Phase 1 | 2023-07-28 |